r
espiratori
viral
infect
among
infant
neonat
intens
care
unit
nicu
result
substanti
morbid
mortal
limit
data
exist
occurr
howev
test
viral
pathogen
perform
routin
mani
nicu
addit
report
preval
respiratori
viral
infect
nicu
center
outbreak
prospect
surveil
clinic
stabl
infant
thu
signific
knowledg
gap
remain
contribut
respiratori
virus
clinic
sign
infect
among
infant
nicu
larg
unknown
infant
evalu
possibl
sepsi
yet
bacteri
cultur
often
steril
diminish
confid
cultur
result
infant
may
receiv
prolong
antibiot
therapi
preterm
infant
nicu
may
classic
cold
symptom
observ
older
infant
children
possibl
viral
respiratori
pathogen
caus
agent
may
consid
advent
new
molecular
technolog
facilit
detect
respiratori
virus
children
adult
yet
technolog
appli
routin
high
risk
infant
nicu
object
studi
determin
frequenc
role
respiratori
viral
infect
detect
polymeras
chain
reaction
pcr
test
among
infant
evalu
possibl
lateonset
sepsi
level
nicu
parkland
memori
hospit
pmh
dalla
texa
women
infant
hospit
wih
provid
rhode
island
prospect
cohort
studi
infant
hospit
nicu
pmh
wih
januari
januari
pmh
nicu
level
predominantli
inborn
unit
approxim
admiss
annual
gown
requir
entranc
area
nicu
neither
use
glove
patient
contact
parent
unlimit
access
except
highacu
area
visit
discourag
noon
daili
patient
round
held
visitor
limit
per
visit
sibl
year
age
may
visit
anytim
parent
sibl
year
age
may
visit
parent
twice
week
supervis
child
life
specialist
must
receiv
recommend
childhood
vaccin
includ
influenza
vaccin
wih
nicu
level
region
facil
compris
predominantli
singlefamili
room
averag
admiss
annual
gown
requir
entranc
area
nicu
neither
routin
use
glove
patient
contact
parent
unlimit
access
may
visitor
per
visit
sibl
age
may
visit
provid
receiv
ageappropri
vaccin
includ
influenza
vaccin
undergo
screen
confirm
lack
fever
respiratori
gastrointestin
symptom
recent
exposur
individu
symptom
parent
visitor
request
perform
fingertiptoelbow
disinfect
scrub
upon
first
enter
infant
room
use
hand
sanit
touch
surfac
handl
infant
infant
elig
inborn
never
discharg
home
evalu
possibl
lateonset
sepsi
antibiot
therapi
initi
hour
age
elig
infant
identifi
daili
review
antibiot
provid
nicu
pharmacist
infant
receiv
antibiot
superfici
skin
surgicalsit
infect
exclud
obtain
inform
consent
enrol
infant
nasopharyng
specimen
collect
detect
respiratori
virus
pcr
within
hour
initi
antibiot
therapi
medic
record
review
pertin
matern
infant
demograph
clinic
radiograph
laboratori
data
discharg
nicu
addit
time
consent
mother
legal
guardian
infant
ask
whether
one
home
symptom
suspect
respiratori
viral
infect
studi
approv
institut
review
board
univers
texa
southwestern
medic
center
wih
rhode
island
hospit
respiratori
specimen
obtain
use
steril
flexibl
flock
nylon
swab
copan
diagnost
inc
murrieta
california
becton
dickinson
co
spark
maryland
insert
nostril
posterior
nasopharynx
subsequ
place
ml
univers
transport
medium
copan
diagnost
inc
becton
dickinson
co
sampl
collect
specimen
provid
number
code
refriger
c
hour
sampl
store
c
ship
dri
ice
microbiolog
laboratori
rhode
island
hospitalbrown
univers
respiratori
viral
pcr
test
perform
technician
blind
patient
ident
site
nasopharyng
specimen
test
batch
multiplex
reversetranscriptasepcr
assay
neonat
infant
age
day
less
hypothermia
defin
axillari
temperatur
c
fever
temperatur
c
respiratori
sign
suggest
infect
includ
rhinorrhea
nasal
congest
cough
tachypnea
breath
per
minut
retract
hypoxia
oxygen
satur
diagnosi
bacteri
pneumonia
base
clinic
find
includ
fever
tachypnea
abnorm
chest
radiograph
andor
prolong
antibiot
therapi
day
tachycardia
beat
per
minut
hypotens
blood
pressur
fifth
percentil
age
infant
time
evalu
vasopressor
therapi
provid
bronchopulmonari
dysplasia
determin
guidelin
propos
jobe
bancalari
central
lineassoci
bloodstream
infect
defin
posit
blood
cultur
clinic
relev
bacteri
pathogen
infant
central
venou
cathet
time
previou
hour
onset
event
without
sourc
infect
diagnosi
urinari
tract
infect
base
neonatologist
assess
medic
record
bacteri
growth
urin
obtain
either
suprapub
bladder
aspir
growth
gramneg
bacilli
coloniesml
gramposit
cocci
catheter
coloniesml
andor
receipt
day
appropri
antibiot
therapi
descript
statist
normal
continu
covari
first
assess
use
kolmogorovsmirnov
test
normal
distribut
data
mean
sd
deriv
descript
statist
eg
patient
demograph
characterist
median
valu
iqr
calcul
nonnorm
distribut
data
appropri
vol
octob
ci
use
compar
differ
mean
median
valu
proport
calcul
categor
data
bivari
analys
perform
determin
associ
depend
variabl
presenc
viru
independ
covari
use
test
normal
distribut
data
mannwhitney
u
test
nonparametr
data
chisquar
fisher
exact
test
use
categor
variabl
appropri
covari
p
bivari
analys
enter
mix
stepwis
logist
regress
model
determin
variabl
independ
predict
viral
infect
maximum
minimum
threshold
signific
level
effect
enter
retain
model
respect
p
consid
statist
signific
studi
period
elig
infant
enrol
infant
pmh
nicu
elig
infant
wih
elig
infant
mothersleg
guardian
pmh
wih
infant
declin
enrol
studi
infant
miss
pmh
addit
infant
die
consent
could
obtain
mother
hispan
deliv
infant
via
cesarean
deliveri
tabl
mother
pmh
infect
hiv
infant
uninfect
none
intrapartum
fever
symptom
suggest
viral
infect
deliveri
infant
mostli
male
preterm
week
gestat
week
gestat
low
birth
weight
g
birth
weight
g
g
tabl
onset
clinic
sign
infect
chronolog
age
evalu
lateonset
sepsi
occur
median
age
day
median
durat
hospit
day
infant
receiv
evalu
initi
antimicrobi
therapi
possibl
sepsi
sepsi
evalu
perform
nasopharyng
swab
collect
sepsi
evalu
eight
infant
sepsi
evalu
respiratori
viru
detect
nasopharyng
swab
includ
infant
pmh
infant
wih
tabl
ii
respiratori
virus
detect
time
first
sepsi
evalu
none
patient
whose
nasopharyng
swab
detect
respiratori
viru
first
evalu
receiv
anoth
sepsi
evalu
therefor
none
retest
respiratori
virus
detect
enterovirusrhinoviru
n
rhinoviru
n
coronavirus
viru
n
luminex
xtag
respiratori
viral
panel
identifi
posit
infant
genmark
esensor
respiratori
viral
panel
detect
infant
rhinoviru
enteroviru
viru
detect
panel
tabl
ii
infant
respiratori
viru
detect
time
sepsi
evalu
hypothermia
n
tachypnea
n
apnea
n
one
fever
one
cough
latter
infant
well
anoth
one
diagnos
pneumonia
due
viru
hematochezia
occur
infant
rhinoviru
neither
diagnos
necrot
enterocol
five
infant
sick
contact
presum
respiratori
viral
infect
three
infant
respiratori
viru
detect
parent
grandpar
nurs
rhinorrhea
infant
respiratori
viru
detect
mother
sibl
cough
sore
throat
rhinorrhea
none
contact
test
viral
infect
overal
main
reason
sepsi
evalu
respiratori
sign
mainli
tachypnea
chest
retract
gastrointestin
sign
princip
feed
intoler
abdomin
distens
tabl
iii
compar
infant
whose
respiratori
viru
pcr
test
neg
infant
respiratori
viru
detect
sepsi
evalu
like
older
vs
day
p
ci
expos
individu
respiratori
viral
symptom
vs
p
ci
rhinorrhea
vs
p
ci
congest
vs
p
ci
lower
total
neutrophil
count
cellsml
vs
cellsml
p
ci
tabl
iii
also
like
test
respiratori
viru
provid
vs
p
ci
howev
infant
respiratori
viru
detect
viru
identifi
provid
test
birth
hospit
tabl
ii
infant
test
provid
also
neg
respiratori
viral
test
result
birth
hospit
tabl
iii
none
infant
respiratori
viru
detect
bacteri
agent
isol
blood
cerebrospin
fluid
one
infant
coronaviru
detect
diagnos
urinari
tract
infect
urin
obtain
suprapub
bladder
aspir
yield
colonyform
unitsml
coagulaseneg
staphylococci
blood
cultur
steril
hand
infant
whose
nasopharyng
swab
detect
respiratori
viru
bacteri
infect
urinari
tract
bacteri
bloodstream
infect
respect
tabl
iii
nine
bloodstream
infect
central
lineassoci
bloodstream
infect
addit
infant
posit
respiratori
viral
pcr
test
median
durat
antibiot
use
day
iqr
vs
median
day
iqr
whose
pcr
neg
p
ci
tabl
iii
also
signific
differ
incid
bronchopulmonari
dysplasia
group
covari
p
bivari
analys
tabl
iii
enter
logist
regress
model
determin
factor
accur
predict
viral
infect
adjust
confound
includ
gestat
age
birth
weight
age
sepsi
evalu
absolut
total
neutrophil
count
exposur
individu
symptom
upper
respiratori
infect
clinic
suspicion
viral
infect
attend
physician
adjust
confound
model
predictor
viral
infect
caregiv
clinic
suspicion
viral
infect
indic
order
viral
studi
independ
studi
protocol
p
exposur
individu
symptom
upper
respiratori
infect
signific
predictor
p
small
studi
use
commerci
avail
pcrbase
respiratori
viral
panel
found
highrisk
infant
evalu
lateonset
sepsi
antibiot
therapi
initi
nicu
respiratori
viru
detect
overal
respiratori
viru
detect
sepsi
evalu
best
predictor
detect
respiratori
viru
infant
nicu
provid
order
respiratori
viral
test
perform
pcrposit
infant
posit
infant
tabl
ii
iii
howev
pmh
direct
fluoresc
antibodi
test
perform
lack
optim
sensit
would
detect
enterovirusrhinoviru
coronavirus
addit
infant
test
mostli
tachypnea
apnea
tabl
iii
result
argu
frequent
test
infant
also
use
optim
molecular
diagnost
methodolog
although
multiplex
assay
use
studi
luminex
xtag
genmark
esensor
panel
offer
larger
menu
potenti
viral
pathogen
compar
tradit
virolog
method
virus
identifi
patient
detect
test
kit
infant
rhinovirusenteroviru
viru
detect
multiplex
pcr
panel
result
like
attribut
differ
composit
multiplex
primer
target
differ
virus
well
lower
limit
detect
viral
particl
assay
find
support
better
sensit
genmark
detect
coronavirus
rhinoviru
infant
posit
enterovirusrhinoviru
luminex
xtag
test
neg
genmark
esensor
panel
could
infect
enteroviru
rather
rhinoviru
enteroviru
detect
genmark
esensor
kit
unfortun
viral
cultur
specif
enterovir
pcr
test
perform
either
infant
similarli
design
studi
infant
evalu
lateonset
sepsi
german
nicu
infant
respiratori
viru
detect
multiplex
pcr
test
rsv
detect
infant
picornavirus
infant
detect
rate
similar
studi
note
also
bacteri
bloodstream
coinfect
detect
occur
enrol
infant
nicu
author
conclud
specif
present
laboratori
marker
differenti
infant
viral
detect
posit
blood
cultur
data
support
nonspecif
clinic
present
rhinorrhea
congest
cough
prospect
surveil
studi
use
multiplex
pcr
test
detect
respiratori
virus
among
infant
nicu
period
bennet
et
al
found
infant
week
gestat
age
test
posit
respiratori
viru
least
birth
hospit
virus
detect
infant
parainfluenza
viru
patient
human
metapneumoviru
patient
rsv
patient
enterorhinoviru
patient
influenza
b
patient
unlik
studi
posit
swab
includ
one
viru
infant
sequenti
posit
specimen
viru
cluster
observ
none
patient
respiratori
viru
detect
sampl
subsequ
undergo
anoth
sepsi
evalu
cluster
posit
infant
either
nicu
also
differ
studi
viral
infect
clinic
recogn
nicu
provid
wherea
infant
respiratori
viru
detect
test
clinic
reason
importantli
howev
bennet
et
al
found
infant
test
posit
respiratori
viru
longer
length
hospit
greater
use
durat
supplement
oxygen
prolong
ventil
support
twice
rate
bronchopulmonari
dysplasia
greater
number
clinic
deterior
event
studi
number
infant
test
posit
respiratori
virus
small
abl
find
signific
associ
variabl
small
sampl
size
studi
made
imposs
evalu
differ
nicu
environ
pmh
share
bay
wih
individu
patient
room
multicent
studi
would
abil
look
differ
viral
infect
rate
differ
nicu
design
could
help
identifi
safer
hospit
practic
may
reduc
risk
viral
infect
similarli
small
sampl
size
lack
real
time
knowledg
result
viral
test
allow
detect
potenti
differ
antibiot
use
among
infant
without
viral
infect
futur
studi
enrol
larger
cohort
infant
rapid
feedback
result
provid
need
determin
respiratori
viral
test
inform
antibiot
stewardship
nicu
limit
studi
includ
small
sampl
size
low
rate
enrol
wih
small
number
infant
respiratori
viru
detect
despit
fact
rsv
influenza
circul
commun
yearlong
studi
one
hand
argu
good
infect
prevent
practic
nicu
horizont
transmiss
seem
occur
base
lack
tempor
spatial
cluster
case
hand
case
repres
health
careassoci
infect
appropri
diagnos
could
lead
optim
strategi
prevent
occurr
anoth
limit
detect
nucleic
acid
respiratori
tract
infant
nicu
could
repres
falseposit
result
prolong
shed
preced
infect
even
colon
rather
acut
infect
strength
studi
prospect
natur
identifi
infant
clinic
sign
possibl
sepsi
studi
potenti
impact
respiratori
viral
infect
nonetheless
number
respiratori
viral
infect
may
underestim
clinic
sign
viral
respiratori
infect
confus
event
like
frequent
desatur
episod
increas
oxygen
requir
bacteri
infect
would
made
infant
elig
studi
question
also
remain
whether
viru
caus
clinic
sign
whether
previous
unidentifi
infect
shed
ongo
latter
issu
may
requir
inclus
healthi
infant
futur
studi
respiratori
viral
test
nicu
addit
futur
studi
involv
microarray
analysi
studi
gene
express
profil
infect
infant
may
help
resolv
issu
differenti
infect
possibl
colon
n
assist
patient
enrol
wih
melodi
bush
rph
sara
mureeba
pharmd
sheeba
tharayil
pharmd
john
gard
pharmd
pmh
nicu
pharmaci
assist
patient
identif
fabio
mosca
md
provid
dr
ronchi
opportun
perform
clinic
research
ut
southwestern
submit
public
mar
last
revis
receiv
may
accept
may
